Back
Verrica Pharmaceuticals Stock Price Chart
Sponsored
VRCA
Sponsored
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Sell
22
VRCA
Verrica Pharmaceuticals
Last Price:
1.94
Seasonality Move:
-10.89%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing slight selling pressure.
Verrica Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.9 | Sell |
20-day SMA: | 2.22 | Sell |
50-day SMA: | 4.56 | Sell |
200-day SMA: | 5.99 | Sell |
8-day EMA: | 1.93 | Sell |
20-day EMA: | 2.44 | Sell |
50-day EMA: | 3.96 | Sell |
200-day EMA: | 5.56 | Sell |
Verrica Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.72 | Sell |
Relative Strength Index (14 RSI): | 23.71 | Sell |
Chaikin Money Flow: | -76106 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.94 - 2.78) | Sell |
Bollinger Bands (100): | (3.83 - 8.77) | Sell |
Verrica Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Verrica Pharmaceuticals Stock
Is Verrica Pharmaceuticals Stock a Buy?
- Verrica Pharmaceuticals share price is 1.86 while VRCA 8-day simple moving average is 1.90, which is a Sell signal.
- The stock price of VRCA is 1.86 while Verrica Pharmaceuticals 20-day SMA is 2.22, which makes it a Sell.
- Verrica Pharmaceuticals 50-day simple moving average is 4.56 while VRCA share price is 1.86, making it a Sell technically.
- VRCA stock price is 1.86 and Verrica Pharmaceuticals 200-day simple moving average is 5.99, creating a Sell signal.
VRCA Technical Analysis vs Fundamental Analysis
Sell
22
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy or a Sell?
-
Verrica Pharmaceuticals stock is rated a Sell
The current Verrica Pharmaceuticals [VRCA] share price is $1.86. The Score for VRCA is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Verrica Pharmaceuticals Stock Info
Market Cap:
79.36M
Price in USD:
1.86
Share Volume:
707.04K
Verrica Pharmaceuticals 52-Week Range
52-Week High:
11.41
52-Week Low:
1.77
Sell
22
Verrica Pharmaceuticals (VRCA)
is a Sell
Verrica Pharmaceuticals Share Price Forecast
-
What is the Verrica Pharmaceuticals stock price today?
The Verrica Pharmaceuticals stock price is 1.86 USD today. -
Will VRCA stock go up or go down?
Verrica Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Verrica Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Verrica Pharmaceuticals is overvalued.
Is Verrica Pharmaceuticals Stock a Buy?
- Verrica Pharmaceuticals share price is 1.86 while VRCA 8-day exponential moving average is 1.93, which is a Sell signal.
- The stock price of VRCA is 1.86 while Verrica Pharmaceuticals 20-day EMA is 2.44, which makes it a Sell.
- Verrica Pharmaceuticals 50-day exponential moving average is 3.96 while VRCA share price is 1.86, making it a Sell technically.
- VRCA stock price is 1.86 and Verrica Pharmaceuticals 200-day simple moving average is 5.56, creating a Sell signal.
Fundamental Analysis of Verrica Pharmaceuticals
Is Verrica Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.68 per share.
Technical Analysis of Verrica Pharmaceuticals
Should I short Verrica Pharmaceuticals stock?
- VRCA Moving Average Covergence Divergence (MACD) indicator is -0.72, suggesting Verrica Pharmaceuticals is a Sell
- Verrica Pharmaceuticals Relative Strength Index (RSI) is 23.71, which suggest Verrica Pharmaceuticals is oversold
- The Bollinger Bands (25) for Verrica Pharmaceuticals is (1.94 - 2.78), which suggest Verrica Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Verrica Pharmaceuticals is (3.83 - 8.77), which suggest Verrica Pharmaceuticals is a Sell
* Verrica Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.